MeSH tree: C15
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (AML) cells, which may help explain why AML is particularly sensitive to immune-based ...
Jul 16, 2026
0
6
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease.
Jul 15, 2026
0
2
New research has uncovered why one of the most widely used treatments for multiple myeloma can cause debilitating nerve and gastrointestinal side effects, marking a significant step toward preventing them.
Jul 15, 2026
0
3
Researchers at The University of Texas MD Anderson Cancer Center have created a comprehensive single-cell map of the tumor immune microenvironment in multiple myeloma and its precursor conditions. The study provided insights ...
Jul 15, 2026
0
2
New research from VCU Massey Comprehensive Cancer Center provides evidence for a combination treatment strategy that uses cells' waste-removal functions to target multiple myeloma. The findings, published recently in Cell ...
Jul 14, 2026
0
5
Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine scientists. To help patients facing aggressive blood cancers overcome this metabolic risk, researchers identified a potential ...
Jul 13, 2026
0
6
A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women and girls with hematological ...
Jul 13, 2026
0
3
Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for treating myeloproliferative neoplasms. A new study from scientists at St. Jude Children's ...
Jul 12, 2026
0
14
Researchers at Karolinska Institutet in Sweden and Kyoto University in Japan have identified new subgroups of the blood cancer acute myeloid leukemia. The study, published in the journal Nature, shows that changes in the ...
Jul 9, 2026
0
6
The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) ...
Jul 9, 2026
0
4
